Allotment of Securities

CSD/NSE&BSE/ESOP/2026-27 Date: June 22, 2026 To To The Department of Corporate Services The Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400001 Bandra (E), Mumbai – 400051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Allotment of 2,71,970 Equity Shares upon exercise of vested Options under SLSL ESOP 2020 Scheme Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the Nomination & Remuneration Committee of Suven Life Sciences Limited (“the Company”) in its meeting held on June 22, 2026 has approved the allotment of 2,71,970 Equity Shares of Rs.1/- issued at exercise price of Rs. 55/- each (including premium of Rs.54/- each), to the eligible employees upon exercise of vested Stock Options under Suven Life Sciences Limited Employee Stock Option Scheme 2020 (SLSL ESOP 2020). Upon such allotment, the paid-up equity share capital of the company stands increased to the following: Particulars No. of Equity Shares Amount in INR Pre-issue subscribed & paid-up capital 26,37,20,583 26,37,20,583.00 Post-issue subscribed & paid-up capital 26,39,92,553 26,39,92,553.00 Statement pursuant to Regulation 10(c) of the SEBI (Share based Employee Benefits and Sweat Equity) Regulations, 2021 is enclosed as Annexure - A. Further, the required information in compliance with SEBI Master Circular No. HO/49/14/14(7) 2025-CFDPOD2/I/3762/2026 dated January 30, 2026, is enclosed herewith as Annexure – B. This is for your information and record. Thanking you, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary Encl.: as above Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor I Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com Annexure-A Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Sl. Items of Disclosure Description 1. Company name and address of Suven Life Sciences Limited Registered Office Address: 8-2-334, SDE Serene Chambers, 6th Floor Road No.5, Avenue 7, Banjara Hills, Hyderabad Telangana, India, 500034. 2. Name of the recognised Stock BSE Limited Exchanges on which the company's National Stock Exchange of India Limited shares are listed 3. Filing date of the statement referred in BSE – December 03, 2020 regulation 10(b) of the Securities and NSE – December 03, 2020 Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with the recognized Stock Exchange: 4. Filing Number, if any: Not Applicable 5. Title of the Scheme pursuant to which Suven Life Sciences Limited Employee Stock shares are issued, if any: Option Scheme 2020 (SLSL ESOP 2020). 6. Kind of security to be listed: Equity Shares 7. Par value of the shares: Rs.1/- each 8. Date of issue of shares: June 22, 2026 9. Number of shares issued: 2,71,970 10. Share Certificate No., if applicable: Not Applicable 11. Distinctive number of the share, if 26,37,20,584 to 26,39,92,553 applicable: 12. ISIN Number of the shares if issued in INE495B01038 Demat: 13. Exercise price per share: Rs.55/- 14. Premium per share: Rs.54/- 15. Total issued shares after this issue: 26,39,92,553 16. Total issued share capital after this Rs. 26,39,92,553.00/- issue: 17. Details of any lock-in on the shares: Not Applicable 18. Date of expiry of lock-in: Not Applicable 19. Whether shares are identical in all Yes, issued shares rank pari-passu with respects to existing shares? If not, when existing shares. will they become identical? 20. Details of listing fees, if payable: Not Applicable Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor I Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com Annexure-B Disclosure under Regulation 30 of the SEBI (Listing and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026 Sl. Items of Disclosure Description 1. Brief details of options granted The present instance is for allotment of Equity Shares upon exercise of 2,71,970 (Two lakhs seventy-one thousand nine hundred seventy only) vested options under SLSL ESOP 2020 Scheme. 2. whether the scheme is in terms Yes of SEBI (SBEB) Regulations, 2021 (if applicable) 3. total number of shares covered The present disclosure is in respect of allotment by these options of 2,71,970 shares 4. pricing formula Not Applicable 5. options vested Not Applicable as the intimation is towards allotment of shares pursuant to exercise of ESOP. 6. time within which option may Not Applicable as the intimation is towards be exercised allotment of shares pursuant to exercise of ESOP. 7. options exercised 2,71,970 were exercised in the current allotment 8. money realized by exercise of Rs.1,49,58,350/- for the current allotment options 9. the total number of shares 2,71,970 equity shares arising as a result of exercise of option 10. options lapsed Not Applicable 11. variation of terms of options Not Applicable 12. brief details of significant terms As per SLSL ESOP 2020 Scheme 13. subsequent changes or Not Applicable cancellation or exercise of such options 14. diluted earnings per share Not Applicable pursuant to issue of equity shares on exercise of options Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor I Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com